N-Vax is filed with the CBE under the catch-all “Overige gespecialiseerde bouwactiviteiten”. Also registered: civil engineering contractor. Private Limited, started on 8 September 2021, 1 establishment.

What is the address of N-Vax?

The registered office of N-Vax is located at Winkelstap 32 box 1, 2170 Antwerpen.

Is N-Vax still active?

Yes. According to the CBE (5 October 2026) N-Vax is active, legal situation “Normale toestand”, started on 8 September 2021.

Is N-Vax registered on Peppol?

Yes, N-Vax is registered on the Peppol network with ID 0208:0773653885.

What is the enterprise number of N-Vax?

The enterprise number of N-Vax is BE0773653885.

When was N-Vax founded?

N-Vax was founded on 8 September 2021.

Who are the directors of N-Vax?

According to the 2025 annual accounts, the directors of N-Vax are: Dominique VAN AGTMAEL.

Is N-Vax a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 September 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did N-Vax make in 2025?

N-Vax recorded a loss after taxes of € 3,657 in financial year 2025.

What is the revenue of N-Vax?

As a small company, N-Vax is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -198.

N-Vax (Private Limited) - Antwerpen - BE0773653885

Dossier N-Vax, printed on 5 October 2026 from databakkes.be/en/0773653885/n-vax. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

N-Vax from Antwerpen, company number BE0773653885, closed financial year 2025 with a result of € -3,657 after tax. For that financial year N-Vax recorded a gross margin of € -198 and equity of € 20,475. Compared with financial year 2024, the result moved from € 13,005 to € -3,657. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Healthy

€ 20,475

▼ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -3,657

▼ still € 13,005 profit in 2024

Profit after tax over the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 18,975.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

€ 7,689

▼ 37% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 6,153

▲ 60% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,288

▲ 21% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 16,017 Gross margin 2022: € 16,017 First fiscal year in the series	€ 1,628 Gross margin 2023: € 1,628 ▼ 90% vs 2022 (€ 16,017) Unfavourable step	€ 21,253 Gross margin 2024: € 21,253 ▲ € 19,625 vs 2023 (€ 1,628) Favourable step	€ -198 Gross margin 2025: € -198 ▼ € 21,451 vs 2024 (€ 21,253) Unfavourable step	▼ € 21,451
Profit after taxes	€ 10,599 Profit after taxes 2022: € 10,599 First fiscal year in the series	€ -1,044 Profit after taxes 2023: € -1,044 ▼ € 11,644 vs 2022 (€ 10,599) Unfavourable step	€ 13,005 Profit after taxes 2024: € 13,005 ▲ € 14,049 vs 2023 (€ -1,044) Favourable step	€ -3,657 Profit after taxes 2025: € -3,657 ▼ € 16,662 vs 2024 (€ 13,005) Unfavourable step	▼ € 16,662
Equity	€ 12,171 Equity 2022: € 12,171 First fiscal year in the series	€ 11,127 Equity 2023: € 11,127 ▼ 9% vs 2022 (€ 12,171) Unfavourable step	€ 24,132 Equity 2024: € 24,132 ▲ 117% vs 2023 (€ 11,127) Favourable step	€ 20,475 Equity 2025: € 20,475 ▼ 15% vs 2024 (€ 24,132) Unfavourable step	▼ 15%
Total debts	€ 12,757 Total debts 2022: € 12,757 First fiscal year in the series	€ 23,126 Total debts 2023: € 23,126 ▲ 81% vs 2022 (€ 12,757) Unfavourable step	€ 30,428 Total debts 2024: € 30,428 ▲ 32% vs 2023 (€ 23,126) Unfavourable step	€ 25,130 Total debts 2025: € 25,130 ▼ 17% vs 2024 (€ 30,428) Favourable step	▼ 17%
Retained profit	€ 10,671 Retained profit 2022: € 10,671 First fiscal year in the series	€ 9,627 Retained profit 2023: € 9,627 ▼ 10% vs 2022 (€ 10,671) Unfavourable step	€ 22,632 Retained profit 2024: € 22,632 ▲ 135% vs 2023 (€ 9,627) Favourable step	€ 18,975 Retained profit 2025: € 18,975 ▼ 16% vs 2024 (€ 22,632) Unfavourable step	▼ 16%
Bank debt	€ 1,139 Bank debt 2022: € 1,139 First fiscal year in the series	€ 8,660 Bank debt 2023: € 8,660 ▲ € 7,521 vs 2022 (€ 1,139) Unfavourable step	€ 12,270 Bank debt 2024: € 12,270 ▲ 42% vs 2023 (€ 8,660) Unfavourable step	€ 7,689 Bank debt 2025: € 7,689 ▼ 37% vs 2024 (€ 12,270) Favourable step	▼ 37%
Balance sheet total	€ 24,929 Balance sheet total 2022: € 24,929 First fiscal year in the series	€ 34,253 Balance sheet total 2023: € 34,253 ▲ 37% vs 2022 (€ 24,929) Unchanged	€ 54,560 Balance sheet total 2024: € 54,560 ▲ 59% vs 2023 (€ 34,253) Unchanged	€ 45,605 Balance sheet total 2025: € 45,605 ▼ 16% vs 2024 (€ 54,560) Unchanged	▼ 16%

Key figures of N-Vax, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to N-Vax?

What happened at N-Vax in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: loss of € 3,657 (▼ € 16,662 vs 2024). filed late Source: NBB ↗
Sep 8, 2021 New establishment in Antwerpen. KBO
Sep 8, 2021 Start of the company according to the CBE. KBO

In short

From € 10,599 profit in 2022 to € 3,657 loss in 2025.

Paid € 9,059 in corporate taxes since 2022.

Best year ever: 2024, with € 13,005 profit.

Original PDFs at the National Bank ↗

A new publication or filing at N-Vax? We notify you, reason included.

Follow N-Vax

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dominique VAN AGTMAEL

N-Vax

Behind N-Vax is Dominique VAN AGTMAEL.

See the full network in the app

Directors

According to the 2025 annual accounts

Dominique VAN AGTMAEL

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Winkelstap 32 box 1

2170 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Acouja

€ 46,954 gross margin · 2025

Plysier

€ 1,386 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0773.653.885

VAT number

BE 0773.653.885

Registered office

Winkelstap 32 bus 1, 2170 Antwerpen

Names & denominations

N-Vax

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 September 2021

Peppol

Active · Active since 24 Dec 2025

Activities · NACE

Overige gespecialiseerde bouwactiviteiten, neg

Overige gespecialiseerde bouwwerkzaamheden

Bouw van andere civieltechnische werken, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

N-Vax

Financials

What happened to N-Vax?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions